Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial

• William D Chey,
• Francis Mégraud,
• Loren Laine,
• Neila Smith,
• Eckhard Leifke,
• Barbara Hunt,
• Colin W Howden

Affiliations

William D Chey

Gastroenterology and Nutrition Sciences, Division of Gastroenterology and Hepatology, Department of Internal Medicine Michigan Medicine Ann Arbor Michigan USA

Francis Mégraud

Emeritus, INSERM U1312 University of Bordeaux Bordeaux France

Loren Laine

Medicine (Digestive Diseases) Yale School of Medicine New Haven Connecticut USA

Neila Smith

Phathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA

Eckhard Leifke

Phathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA

Barbara Hunt

Phathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA

Colin W Howden

Emeritus, Department of Medicine University of Tennessee College of Medicine Memphis Tennessee USA